Pieris Pharmaceuticals

1 follower

‌

Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.

Industries

Headquarters

Employees

Links

Org chart

Stephen S. Yoder

President & CEO

Stephen S. Yoder

Collapse

Tom Bures

SVP & CFO

Shane Olwill

SVP & Chief Development Officer

Mary Fitzgerald

VP, Project Leader PRS-060/AZD1402

Frank Vollmering

VP, Human Resources

Florian Witte

VP & Head of Alliance Management and Early-Stage Project Leadership

Teams

+17

Board Members

20 members

Leadership Team

6 members

Similar companies

Rocket Pharmaceuticals

2 followers

Astria Therapeutics

1 follower

Bristol-Myers Squibb

163 followers

Walgreens Boots Alliance

103 followers

ADARx Pharmaceuticals

2 followers

Viatris

30 followers

Syneos Health

16 followers

Charlie Health

4 followers

AbbVie

149 followers

Umoja Biopharma

3 followers

Windfall

3 followers

Discover companies